CVR number 29140103
Industry 32.5000 Manufacture of medical and dental instruments and supplies

GREGERSEN DENTAL ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Bankruptcy risk for industry  2.2% 2.2% 2.2% 2.2% 2.2%  
Bankruptcy risk  1.4% 1.3% 2.0% 2.3% 5.4%  
Credit score (0-100)  79 80 68 65 41  
Credit rating  A A A BBB BBB  
Credit limit (kDKK)  13.0 45.9 0.6 0.1 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales  0 0 0 0 0  
Gross profit  1,780 3,077 2,705 2,611 2,164  
EBITDA  238 1,024 746 249 16.5  
EBIT  224 1,010 721 249 16.5  
Pre-tax profit (PTP)  212.3 991.0 695.0 234.6 13.9  
Net earnings  162.9 767.8 538.6 181.1 8.5  
Pre-tax profit without non-rec. items  212 991 695 235 13.9  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Tangible assets total  38.4 24.5 0.0 0.0 0.0  
Shareholders equity total  579 1,347 1,885 1,566 1,575  
Interest-bearing liabilities  543 267 384 24.5 373  
Balance sheet total (assets)  1,466 2,329 2,616 2,379 2,144  
Net Debt  -761 -1,540 -1,865 -2,053 -1,396  
 
See the entire balance sheet

Volume 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,780 3,077 2,705 2,611 2,164  
Gross profit growth  -6.8% 72.8% -12.1% -3.5% -17.1%  
Employees  4 5 5 4 4  
Employee growth %  0.0% 25.0% 0.0% -20.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,466 2,329 2,616 2,379 2,144  
Balance sheet change%  3.6% 58.8% 12.3% -9.0% -9.9%  
Added value  238.4 1,024.2 745.6 273.0 16.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -28 -28 -49 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  12.6% 32.8% 26.7% 9.5% 0.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  15.6% 53.2% 29.2% 10.0% 0.7%  
ROI %  19.4% 72.5% 37.1% 12.9% 0.9%  
ROE %  32.8% 79.8% 33.3% 10.5% 0.5%  

Solidity 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Equity ratio %  39.5% 57.8% 72.1% 65.8% 73.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -319.2% -150.3% -250.2% -826.0% -8,439.5%  
Gearing %  93.8% 19.8% 20.4% 1.6% 23.7%  
Net interest  0 0 0 0 0  
Financing costs %  1.9% 4.8% 8.0% 6.8% 1.3%  

Liquidity 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Quick Ratio  1.7 2.3 3.6 2.9 10.9  
Current Ratio  1.7 2.3 3.6 2.9 10.9  
Cash and cash equivalent  1,304.0 1,806.5 2,249.7 2,077.5 1,768.6  

Capital use efficiency 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  592.0 1,322.1 1,885.1 1,566.2 1,947.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales / employee  0 0 0 0 0  
Added value / employee  60 205 149 68 4  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  60 205 149 62 4  
EBIT / employee  56 202 144 62 4  
Net earnings / employee  41 154 108 45 2